Stop Sepsis Through Home Monitoring Cooperative

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

In this study, patients presenting with acute infections at risk of developing sepsis will be followed in their home setting using wearables that provide (semi-)continue monitoring of vital signs as well as through follow up using a designated smartphone application. This is an innovative pilot study that will examine the potential of transmural care through telemonitoring for the first time in patients at risk for developing sepsis. By allowing for active follow-up of vital parameters in a transmural setting, this project aims to reduce the number of hospitalizations as compared to current practice. Furthermore, we aim to the number of patients referred to the emergency department after a visit at their primary care physician. Thereby, we aim to reduce the healthcare burden, yet providing the ability for rapid intervention in case of detarioration of patients, thereby reducing morbidity and mortality as well as associated costs.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• This study will include patients aged 18 years or older, capable of giving informed consent, presenting with signs of severe acute infection with a risk of developing sepsis at the emergency department or at their primary care physician.

Locations
Other Locations
Belgium
Antwerp University Hospital (UZA)
RECRUITING
Edegem
Contact Information
Primary
Celine Maes, PHD
thuisopvolging@uza.be
+32 3 436 81 65
Time Frame
Start Date: 2025-02-01
Estimated Completion Date: 2025-12-31
Participants
Target number of participants: 120
Treatments
Other: (semi)continue monitoring of patients at risk for sepsis at home
Patients with acute infections at risk of developing sespsis will be followed in their home setting using wearables that provide (semi-)continue monitoring of vital signs as well as through follow up using a desingated smarthphone application.
Related Therapeutic Areas
Sponsors
Leads: University Hospital, Antwerp

This content was sourced from clinicaltrials.gov